Drug firm Novartis India today said its net profit declined by 8.89% to Rs 39.34 crore for the quarter ended September 30, 2012 over the same period last fiscal.
The company had posted a net profit of Rs 43.18 crore for the quarter ended September 30, 2011, Novartis India said in a statement.
Net sales of the company, however, rose to Rs 237.43 crore for the quarter under consideration from Rs 218.97 crore for the corresponding period previous fiscal.
Novartis India is a part of pharma major Novartis. The Switzerland headquartered firm has core businesses in pharmaceuticals, vaccines, consumer health, generics, eye care and animal health.
Shares of Novartis India today closed at Rs 687.10 per scrip on BSE, up 1.82% from its previous close.
